Clinical trials
Hyperlipoproteinemia Type II trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 6 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Isfahan University of Medical Sciences | 2 |
| Medical University of Vienna | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assiut University | 1 |
| Centre Hospitalier du Luxembourg | 1 |
| China Cardiovascular Association | 1 |
| Chong Kun Dang Pharmaceutical | 1 |
| Federico II University | 1 |
| Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | 1 |
| Imperial College London Diabetes Centre | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipoproteinemia Type II | 30 |
| Cardiovascular Diseases | 5 |
| Atherosclerosis | 4 |
| Hypercholesterolemia | 3 |
| Diabetes Mellitus | 2 |
| Acute Coronary Syndrome | 1 |
| Aortic Valve Stenosis | 1 |
| Arteriosclerosis | 1 |
| Calcinosis | 1 |
| Carotid Stenosis | 1 |
Trials
Showing 51 to 30 of 30. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.